Intraocular Hemorrhage After Intra-Arterial Chemotherapy for Retinoblastoma in Sickle Cell Trait

被引:4
|
作者
Abramson, David H. [1 ]
Marr, Brian P. [1 ]
Brodie, Scott E. [2 ]
Dunkel, Ira J. [3 ]
Lin, Amy [4 ]
Folberg, Robert [5 ,6 ,7 ]
Gobin, Y. Pierre [8 ,9 ,10 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Ophthalm Oncol Serv, 70 East 66th St, New York, NY 10021 USA
[2] Mt Sinai Sch Med, Dept Ophthalmol, New York, NY USA
[3] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
[4] Univ Illinois, Dept Pathol, Chicago, IL USA
[5] Oakland Univ, William Beaumont Sch Med, Dept Biomed Sci, Rochester, MI USA
[6] Oakland Univ, William Beaumont Sch Med, Dept Ophthalmol, Rochester, MI USA
[7] Oakland Univ, William Beaumont Sch Med, Dept Pathol, Rochester, MI USA
[8] Weill Cornell Med Coll, Dept Neurosurg, Intervent Neuroradiol Serv, New York, NY USA
[9] Weill Cornell Med Coll, Dept Neurol, Intervent Neuroradiol Serv, New York, NY USA
[10] Weill Cornell Med Coll, Dept Radiol, Intervent Neuroradiol Serv, New York, NY USA
来源
关键词
Retinoblastoma; sickle cell; intra-arterial chemotherapy; enucleation;
D O I
10.2174/1874364101206010001
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Massive intraocular hemorrhage developed in a child with advanced unilateral retinoblastoma after intrarterial treatment with Melphalan and Topotecan. The child tested positive for sickle cell trait. Sickle cell trait may predispose such children to slower vascular transit time, hypoxia, sickling and vascular occlusion caused by catheter induced decreased flow. Enucleation confirmed the ultrasound and selective angiogram findings in addition to a completely calcified tumor. Clinicians should be on the lookout for the association of sickle-cell disease/trait and intraocular hemorrhages after intraarterial chemotherapy to fully understand its clinical significance.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [41] Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization
    Klufas, M. A.
    Gobin, Y. P.
    Marr, B.
    Brodie, S. E.
    Dunkel, I. J.
    Abramson, D. H.
    AMERICAN JOURNAL OF NEURORADIOLOGY, 2012, 33 (08) : 1608 - 1614
  • [43] Lessons Learned After 500 Cases of Intra-Arterial Chemotherapy for Retinoblastoma
    Atallah, Elias
    Tjoumakaris, Stavropoula I.
    Rosenwasser, Robert H.
    Jabbour, Pascal
    NEUROSURGERY, 2017, 64 : 225 - 226
  • [44] Incidence and Risk Factors for Neutropenia After Intra-Arterial Chemotherapy for Retinoblastoma
    Lee, Debora H.
    Donkor, Richard
    Parvus, Matthew N.
    Dannenbaum, Mark J.
    Schefler, Amy C.
    JAMA OPHTHALMOLOGY, 2023, 141 (12) : 1133 - 1138
  • [46] Intra-arterial chemotherapy for retinoblastoma: transradial and transfemoral approach
    Sweid, Ahmad
    Jabbour, Pascal
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2020, 12 (08) : 828 - 828
  • [47] INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: FIRST AUSTRALIAN EXPERIENCE
    Sachdev, Nisha
    Staffieri, Sandra
    McKenzie, John
    Elder, James
    Heath, John
    Downie, Peter
    Mitchell, Peter
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 : 79 - 79
  • [48] HYPOPITUITARISM FOLLOWING OPHTHALMIC INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA
    Golani, Khushboo
    Madrinan-Navia, Humberto Jose
    Hoyos-Martinez, Alfonso
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 92 - 93
  • [49] Radiation Exposure During Intra-arterial Chemotherapy for Retinoblastoma
    Gobin, Y. Pierre
    Rosenstein, Leonard M.
    Marr, Brian P.
    Brodie, Scott E.
    Abramson, David H.
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (03) : 403 - 404
  • [50] Intra-arterial chemotherapy for retinoblastoma: Centralization of care is essential
    Chantada, Guillermo L.
    Ceciliano, Alejandro
    PEDIATRIC BLOOD & CANCER, 2024, 71 (02)